Back to AUPH
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
5
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA9/19/2024
Vevizye
Treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca) in adult patients, which has not improved despite treatment with tear substitutes.
View on EMAEMA7/6/2018
Verkazia
Treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents.
OrphanAccelerated
View on EMAEMA3/19/2015
Ikervis
Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
View on EMADrug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts